| 标题 |
EX103, a Novel CD20xCD3 Bispecific Antibody, Showed a Favorable Safety and Potent Single-Agent Antitumor Activity in Heavily Pretreated Relapsed/Refractory Patients with B-Cell Non-Hodgkin Lymphoma |
| 网址 | |
| DOI |
10.1182/blood-2023-173486
doi
|
| 其它 |
期刊:Blood 作者:Junyuan Qi; Mingyuan Sun; Keshu Zhou; Chunyan Ji; Fei Lu; et al 出版日期:2023-11-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)